Stephan Windecker
Hat mitgewirkt an:
-
Charakterisierung eines mammakarzinomassoziierten Antigens (TAG-12) mit monoklonalen Antikörpern und Entwicklung eines Radioimmunoassys [Radioimmunoassays] zur quantitativen Bestimmung von TAG-12 in...
-
Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial):...
-
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent : : 5-year outcomes of the randomized BIOFLOW-II trial
-
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis